Advertisement
Screener

ZYMEWORKS INC. (ZYME) Net Margin

ZYMEWORKS INC. (ZYME) Net Margin

  • 2026-06-30: Net Margin -980.81%.
  • 2026-03-31: Net Margin -1833.97%.
  • 2025-12-31: Net Margin -1638.53%.
  • 2025-09-30: Net Margin -70.99%.

Complete source-backed net margin history.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-980.81%
2026-03-31-1833.97%
2025-12-31-1638.53%
2025-09-30-70.99%
2025-06-304.76%
2025-03-31-83.50%
2024-12-31-75.75%
2024-09-30-186.56%
2024-06-30-195.84%
2024-03-31-315.58%
2023-12-31-85.56%
2023-09-30-173.80%
2023-06-30-730.53%
2023-03-31-68.45%
2022-12-3176.88%
2022-09-30-1818.55%
2022-06-30-1187.41%
2022-03-31-3790.45%
2021-12-31-197.04%
2021-09-30-1378.36%

Annual Net Margin

DateNet Margin
2025-12-31-76.56%
2024-12-31-160.80%
2023-12-31-156.13%
2022-12-3130.14%
2021-12-31-794.01%
2020-12-31-463.54%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
AGIOS PHARMACEUTICALS, INC. (AGIO)United States$1.962B-5.38
Biohaven Ltd. (BHVN)United States$1.990B-3.83
COMPASS Pathways plc (CMPS)$1.812B-4.87
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
Nuvation Bio Inc. (NUVB)United States$2.007B-13.12
UroGen Pharma Ltd. (URGN)$2.015B-18.42
Septerna, Inc. (SEPN)United States$1.783B-63.01
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Xencor Inc (XNCR)United States$1.776B-7.33